BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

6/24/2026

DEA to Temporarily Schedule O-Desmethyltramadol in Schedule I

The Drug Enforcement Administration is issuing a temporary order to schedule O-desmethyltramadol, a pain medication, in the most restrictive category of the Controlled Substances Act, effective upon publication, due to concerns over its potential for abuse and addiction.

6/24/2026

FDA Releases Revised Draft Guidance for Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

The Food and Drug Administration (FDA) has released a revised draft guidance for the pharmaceutical industry, titled "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products," in response to public comments and changes in drug development. The guidance aims to provide a more efficient and rigorous approach to generating scientific evidence for drug effectiveness.

6/24/2026

FDA Announces Final Guidance on Anthelmintic Effectiveness for Veterinary Use

The US Food and Drug Administration (FDA) has released a final guidance document, GFI #90, outlining general recommendations for the effectiveness of anthelmintics in animal species, developed in collaboration with the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).

6/24/2026

FDA Announces Final Guidance on Anthelmintic Effectiveness for Bovines

The Food and Drug Administration (FDA) has released a final guidance for industry (GFI) #95, developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), providing study design recommendations for bovines to ensure universal acceptance of anthelmintic effectiveness data for animal species.

6/24/2026

FDA Announces Final Guidance on Anthelmintic Effectiveness for Veterinary Use

The Food and Drug Administration (FDA) has released a final guidance for industry (GFI) #96, developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), providing study design recommendations for ovines to facilitate universal acceptance of anthelmintic drug effectiveness data.

6/24/2026

FDA Releases Guidance on Anthelmintic Drugs for Caprines

The US Food and Drug Administration (FDA) has released a final guidance document (GFI #97) titled 'Effectiveness of Anthelmintics: Specific Recommendations for Caprines' to help the animal health industry develop studies on the effectiveness of anthelmintic drugs for goats and sheep. This document was developed by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) for veterinary use.

6/24/2026

FDA Announces Final Guidance for Veterinary Use of Anthelmintics in Canines

The Food and Drug Administration (FDA) has released a final guidance for the veterinary industry, developed in collaboration with the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), to provide study design recommendations for evaluating the effectiveness of anthelmintics in dogs.

6/24/2026

International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Felines; Guidance for Industry; Availability

The Food and Drug Administration (FDA) has released a final guidance for industry (GFI #113) titled "Effectiveness of Anthelmintics: Specific Recommendations for Felines," which provides study design recommendations for veterinary use to facilitate the acceptance of anthelmintic drug data for felines, in line with national and regional requirements.

6/24/2026

FDA Announces Final Guidance for Effectiveness of Anthelmintics in Chickens

The US Food and Drug Administration (FDA) has released a final guidance document, GFI #114, outlining specific recommendations for the effectiveness of anthelmintics in chickens, developed in collaboration with the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).

6/24/2026

FMCSA Extends Exemption for Rail Industry Workers

The Federal Motor Carrier Safety Administration (FMCSA) has provisionally renewed the exemption for the Association of American Railroads and the American Short Line and Regional Railroad Association, allowing their employees to drive beyond the 14-hour work shift and 60/70 hour on-duty limits for up to four months, pending a final decision on a five-year renewal application.

6/24/2026

FAA Modifies Class E Airspace at Omak Airport, Washington

The Federal Aviation Administration (FAA) has made a minor change to the Class E airspace area at Omak Airport in Washington state, clarifying the airspace description without affecting its substance, as part of a rule published on June 11, 2026

6/24/2026

Modification of Class E Airspace at Ralph Wien Memorial Airport, Kotzebue, AK

The Federal Aviation Administration (FAA) has modified the Class E airspace at Ralph Wien Memorial Airport in Kotzebue, Alaska, to enhance safety and efficiency for instrument flight rule (IFR) operations at the airport, following a proposal by the FAA to optimize instrument flight procedure containment.

6/24/2026

Southwest Power Pool, Inc. Announces Refund for Section 206 Proceeding

Southwest Power Pool, Inc. has announced the effective date of a refund for a Section 206 proceeding, which was initiated by a group of utilities including AEP Oklahoma Transmission Company, Inc., Evergy Kansas Central, Inc., and others, to provide a refund to customers.

6/24/2026

3nStar, Inc. Secures Authorization for FTZ 32 Production Activity

3nStar, Inc. has received authorization to activate production activity in Foreign-Trade Zone (FTZ) 32, located in Doral, Florida, for the deployment of point of sale terminals. This authorization is a significant step forward for the company in expanding its operations in the FTZ.